Mikhail Blagosklonny is known as Misha to many. He holds an MD, Ph.D. degree. Currently, he is serving as a Professor of Oncology. This is at the Roswell Park Cancer Institute located in Buffalo, New York.
Mikhail Blagosklonny is a highly accomplished scientist. He is the author of several journals. He is an editor too. His interest lies in research in various areas. These areas of interests include molecular biology, cellular biology along with clinical investigations.
He is in the study of the tumor along with oncogenes. He likes to study cell cycle along with signal transduction. Next is apoptosis, mitosis besides anticancer therapeutics. Mikhail Blagosklonny is focused on translating basic science into new kind of strategies for fighting cancer. This would include exploiting the cancer cells cycle. Another is the drug resistance for protecting the normal cells in a selective manner.
He is an experienced scientist. This is why Mikhail Blagosklonny has extended his approach towards studying several other diseases that are related to the subject of aging. Hence he has come out with drugs which can be used to prevent aging. These would include drugs like rapamycin.
Mikhail Blagosklonny is the author of several publications. He is the person behind the theory of hyper function. He is also responsible for the theory of aging. He has several anticancer approaches. These are known as chemotherapeutic engineering along with cell cyclotherapy.
Mikhail Blagosklonny is a keen researcher. He likes to spend most of his time in trying to solve all those problems that affect human beings. The scientist has managed to publish nearly three hundred articles, book chapters, as well as different reviews that are based on research.
He is the brain behind Cell Cycle. He is serving as its Editor as well as Editor-in-Chief. Mikhail Blagosklonny is the co-founder of Aging and Oncortarget, as well as Oncoscience. He is also the co-editor of Oncoscience.
He is the associate editor of Cancer Biology and Therapy, Cancer Research, besides Autophagy and International Journal of Pathology. He is also the Associate Editor of Cell Death and Differentiation besides PLOS ONE.
Mikhail Blagosklonny is still serving in all these positions as he has gained wide experience over the years. His interests have helped in devising ways for dealing with cancer. His research that is being done in cancer as well as in targeted cancer therapies has effective results in the modern world.
There is a hypothesis that has been formulated by Mikhail Blagosklonny. It is regarding the possible role of TOR signaling that can be seen in aging along with cancer. Next is about the use of rapamycin. This is a known drug. Mikhail Blagosklonny is considering it as a possible treatment that can be used for life extension. He is quite passionate about using rapamycin for longevity.
Mikhail Blagosklonny continues doing research in all the areas that are mentioned above. This way he has been able to shape the approach of modern science towards cancer as well as longevity by making it innovative. Visit classroomvoices.org to read more about Mikhail.